共 50 条
- [1] Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer [J]. RADIATION ONCOLOGY, 2013, 8
- [2] A Dosimetric and Clinical Evaluation of Monotherapy With Hypofractionated Stereotactic Body Radiation Therapy in the Treatment of Intermediate-Risk Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S827 - S827
- [3] Toxicity and Quality of Life After Hypofractionated Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S604 - S604
- [4] Low incidence of new biochemical and clinical hypogonadism following hypofractionated stereotactic body radiation therapy (SBRT) monotherapy for low- to intermediate-risk prostate cancer [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2011, 4
- [6] Pooled Analysis of High-Dose-Rate Brachytherapy or Stereotactic Body Radiation Therapy Monotherapy for Intermediate-Risk Prostate Cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E214 - E214
- [7] Combined hypofractionated radiation and hormone therapy for the treatment of intermediate-risk prostate cancer [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (01): : 58 - 63
- [8] Hypofractionated Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer: A Multi-institutional Phase 2 Analysis [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E197 - E198
- [10] Hypofractionated stereotactic body radiotherapy in low- and intermediate-risk prostate carcinoma [J]. RADIATION ONCOLOGY JOURNAL, 2016, 34 (04): : 260 - 264